28th June 2023: speech at IMIG
On 28th June, Dr Andrea Lamarca, researcher in HMGBiotech lab, will give a speech at IMIG2023, the International Mesothelioma Interest Group conference.
28th June 2023: speech at IMIG Read More »
On 28th June, Dr Andrea Lamarca, researcher in HMGBiotech lab, will give a speech at IMIG2023, the International Mesothelioma Interest Group conference.
28th June 2023: speech at IMIG Read More »
HMGBiotech participated in a recent study in which, through an integrative structural approach, molecular details of HMGB1●CXCL12 heterocomplex formation were unveiled.
HMGB1●CXCL12 : the first fuzzy chemokines heterocomplex reported so far Read More »
The interaction between SDF-1 chemokine protein (CXCL12) and HMGB1 generates an heterocomplex which plays an unique role in homeostatic regulation.
Combination kit SDF-1 chemokine protein (CXCL12) with HMGB1 isoforms Read More »
Contact us if you want a dedicated consulting or if you have any questions about our products
Pre-sales consulting and questions Read More »
Disulfide-HMGB1 is a recombinant protein that can induce cytokine and chemokine production in monocytes and other inflammatory cells.
Discover our oxidized HMGB1 protein (disulfide-HMGB1) Read More »
Deeplearning language model applied to design proteins sequence
Deeplearning language model & design proteins sequence Read More »
HMGBiotech Srl will join IMIG2023 through a workshop speech by Dr. Andrea Lamarca.
HMGBiotech will join IMIG2023 Read More »
HMGBiotech provides an explorative kit to test different redox isoforms of HMGB1.
HMGB1 isoforms explorative kit Read More »
Further research is needed to fully understand the potential benefits and challenges associated with targeting the HMGB1-CXCL12-CXCR4 axis.
HMGBiotech Srl at RENOIR ITN Wokshop on muscle tissue repair and disorders. Read More »